London, 11 May 2015 – Technavio has published a new report on the global hemodialysis market, which is expected to grow at a CAGR of nearly 5% from 2015-2019.
Hemodialysis: About the Report
Hemodialysis is an important medical procedure that plays a major role in improving a patient’s quality of life. With the growing prevalence of end-stage renal disease (ESRD), the global hemodialysis market is expected to proliferate.
“Men with chronic kidney disease are 50% more likely to progress to ESRD than women,” says Faisal Ghaus, Vice President of Technavio.
“In the US, ESRD incidence is highest among adults aged 20-44 years. However, globally, ESRD is most prevalent in adults over 70 years of age.”
The latest report by Technavio also emphasizes the increasing popularity of at-home hemodialysis. As waiting lists for kidney transplants lengthen, the popularity of home hemodialysis is expected to grow.
“At-home hemodialysis is a much more flexible treatment option, since patients do not have to schedule appointments. This makes it a much more comfortable process, which is boosting the market demand for the treatment,” says Ghaus.
Hemodialysis: Market Scope and Calculation of Market Size
The new Technavio report covers the present scenario and the growth prospects of the global hemodialysis market from 2015-2019. To calculate the market size, we have considered revenue generated from products and services for the treatment of renal diseases.
Key Information Covered in the Report:
Key Vendors:
- Baxter International Inc.
- B. Braun Melsungen AG
- DaVita Healthcare Partners Inc.
Market Growth Drivers:
- Growing prevalence of ESRD
- For a full detailed list, view our report.
Market Challenges:
- Risks associated with hemodialysis treatment
- For a full detailed list, view our report.
Market Trends:
- Increase in popularity of home hemodialysis
- For a full detailed list, view our report.
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
